Flipping hosts in hyperfine fields of paramagnetic guests
Source abstract
Abstract
Nuclear magnetic resonance (NMR) spectroscopy of paramagnetic systems is an advancing field that contributes to characterization of the structure and magnetism of molecules, molecular assemblies, biomolecules, and materials. In this account, we utilize the hyperfine field intrinsic to ruthenium(III) coordination compounds to uncover details of their supramolecular host-guest binding with cyclodextrins. We interpret perturbations of the 1H NMR shifts of the host to suggest the binding mode of the interaction. We demonstrate how the size of the cyclodextrin cavity and the structural modification of the guest affect whether the binding occurs through a head or tail portal of the cyclodextrin and attempt to explain the observed differences in terms of molecular shapes and the charge-distribution complementarity between the host and guest. Paramagnetic NMR spectroscopy of host-guest systems is shown to be a useful tool for supramolecular and structural chemists investigating modes of molecular encapsulation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Metal complexes synthesis and properties · Advanced NMR Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
2. Ligand-targeted drug delivery10.1021/acs.chemrev.7b00013 ↗
3. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release10.1021/acs.chemrev.5b00346 ↗
4. Drug delivery by supramolecular design10.1039/C7CS00391A ↗
5. Biomedical applications of supramolecular systems based on host–guest interactions10.1021/cr500392w ↗
6. Supramolecular prodrugs based on host–guest interactions10.1039/C9CS00622B ↗
7. Macrocycles as drug-enhancing excipients in pharmaceutical formulations10.1007/s10847-021-01055-9 ↗
8. Introduction and general overview of cyclodextrin chemistry10.1021/cr970022c ↗
9. Cyclodextrin drug carrier systems10.1021/cr970025p ↗
10. Cyclodextrin-based formulations: a non-invasive platform for targeted drug delivery10.1111/bcpt.12917 ↗
11. Influence of intramolecular hydrogen bonds on the binding potential of methylated β-cyclodextrin derivatives10.3762/bjoc.8.218 ↗
12. Heads or tails? Sandwich-type metallo complexes of Hexakis(2,3-di-O-methyl)-α-cyclodextrin10.1021/acs.cgd.0c00532 ↗
13. Cyclodextrin-based catenanes and rotaxanes10.1021/cr970049w ↗
14. Cyclodextrin metal–organic frameworks and their applications10.1021/acs.accounts.0c00695 ↗
15. Cyclodextrin-based molecular machines10.1021/ar000174l ↗
16. Complexation thermodynamics of cyclodextrins10.1021/cr970015o ↗
17. Static and dynamic behavior of 2:1 inclusion complexes of cyclodextrins and charged porphyrins in aqueous organic media10.1021/ja020253n ↗
18. 1:1 and 1:2 complexes between long-chain surfactant and α-cyclodextrin studied by NMR10.1021/jp0370268 ↗
19. Formation of host-guest complexes of β-cyclodextrin and perfluorooctanoic acid10.1021/jp110806k ↗
20. Inclusion of chrysin in β-cyclodextrin and its biological activities10.1016/j.jddst.2016.01.002 ↗
21. Dynamic enzymatic synthesis of γ-cyclodextrin using a photoremovable hydrazone template10.1016/j.chempr.2021.05.013 ↗
22. Modes of micromolar host–guest binding of β-cyclodextrin complexes revealed by NMR spectroscopy in salt water10.1021/acs.joc.0c02917 ↗
23. Molecular encapsulation of transition metal complexes in cyclodextrins. Part 3. Structural consequences of varying the guest geometry in channel-type inclusion compounds10.1039/dt9910002749 ↗
24. Carbohydrate complexes of platinum-group metals10.1021/cr9903050 ↗
25. Cyclodextrins as supramolecular hosts for organometallic complexes10.1021/cr050576c ↗
26. The X-ray crystal structure of a 1:1 adduct between α-cyclodextrin and cyclobutane-1,1-dicarboxylatodiammineplationum( II )10.1039/C39850001602 ↗
27. Second sphere coordination adducts of phosphane-transition metal complexes with ?-Cyclodextrin and its methylated derivative10.1002/anie.198811841 ↗
28. Selective isolation of gold facilitated by second-sphere coordination with α-cyclodextrin10.1038/ncomms2891 ↗
29. Long-lived, highly luminescent rhenium(I) complexes as molecular probes: intra- and intermolecular excited-state interactions10.1021/ja00071a036 ↗
30. Supramolecular coronation of platinum(II) complexes by macrocycles: structure, relativistic DFT calculations, and biological effects10.1021/acs.inorgchem.1c02467 ↗
31. Through-space paramagnetic NMR effects in host–guest complexes: potential ruthenium(III) metallodrugs with macrocyclic carriers10.1021/acs.inorgchem.7b03233 ↗
32. Zwitterionic Ru(III) complexes: stability of metal–ligand bond and host–guest binding with cucurbit[7]uril10.1021/acs.inorgchem.0c01328 ↗
33. Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development10.1039/C7CS00332C ↗
34. Metal drugs and the anticancer immune response10.1021/acs.chemrev.8b00396 ↗
35. Classification of metal-based drugs according to their mechanisms of action10.1016/j.chempr.2019.10.013 ↗
36. Toward multi-targeted platinum and ruthenium drugs -A new paradigm in cancer drug treatment regimens?10.1021/acs.chemrev.8b00271 ↗
37. Stimuli-responsive therapeutic metallodrugs10.1021/acs.chemrev.8b00209 ↗
38. Bertini · 2016
39. Interpreting the paramagnetic NMR spectra of potential Ru(III) metallodrugs: synergy between experiment and relativistic DFT calculations10.1021/jacs.6b02749 ↗
40. NMR studies of cyclodextrins and cyclodextrin complexes10.1021/cr970019t ↗
41. Magnetic susceptibility in paramagnetic NMR10.1016/S0079-6565(02)00002-X ↗
42. Isotropic nuclear resonance shifts10.1063/1.1744723 ↗
43. Theory of isotropic hyperfine interactions in π-electron radicals10.1063/1.1744052 ↗
44. Isotropic NMR shifts in transition metal complexes: the calculation of the fermi contact and pseudocontact terms
45. Solution of a puzzle: high-level quantum-chemical treatment of pseudocontact chemical shifts confirms classic semiempirical theory10.1021/acs.jpclett.0c02462 ↗
46. Hyperfine effects in ligand NMR: paramagnetic Ru(III) complexes with 3-substituted pyridines10.1021/acs.inorgchem.7b02440 ↗
47. Relativistic DFT calculations of hyperfine coupling constants in 5d Hexafluorido complexes: [ReF 6 ] 2− and [IrF 6 ] 2−10.1002/chem.201704653 ↗
48. Nature of NMR shifts in paramagnetic octahedral Ru(III) complexes with axial pyridine-based ligands10.1021/acs.inorgchem.2c03282 ↗
49. Structural studies of the inclusion compounds of α-naphthaleneacetic acid in heptakis(2,6-di-O-methyl)-β-Cyclodextrin and heptakis(2,3,6-tri-O-methyl)-β-Cyclodextrin by X-ray crystallography and molecular dynamics10.1007/s10847-018-0824-y ↗
50. Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities10.1016/j.ejps.2006.10.008 ↗
51. Microencapsulation thermodynamics of methylated β-cyclodextrins with bile salt: enthalpy, entropy, and solvent effect10.1007/s10847-017-0716-6 ↗
52. Supramolecular properties of amphiphilic adamantylated azo dyes10.1016/j.dyepig.2021.109420 ↗
53. Theoretical analysis of the long-distance limit of NMR chemical shieldings10.1063/5.0088162 ↗
54. Aquation of the anticancer complex trans-[RuCl 4 (Him) 2 ] – (Him = imidazole)10.1039/DT9940003305 ↗
55. Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(iii) complex NAMI-A by interactions with human serum albumin10.1039/c0dt01168a ↗
56. Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR10.1007/s00775-009-0578-5 ↗
57. Pyridine analogues of the antimetastatic Ru(III) complex NAMI-A targeting non-covalent interactions with albumin10.1021/ic202029e ↗
58. Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions10.1002/chem.201302671 ↗
59. Closure of the cavity in permethylated cyclodextrins through glucose inversion, flipping, and kinking10.1002/(SICI)1521-3773(19981231)37:24<3404::AID-ANIE3404>3.0.CO;2-G ↗
60. Unusual 1C4 conformation of a methylglucose residue in crystalline permethyl-β-cyclodextrin monohydrate10.1039/P29940002071 ↗
61. Mechanochemical enhancement of the structural stability of pseudorotaxane intermediates in the synthesis of rotaxanes10.1021/jacs.2c00515 ↗
62. Managing the computational chemistry big data problem: the ioChem-BD platform10.1021/ci500593j ↗